Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have found that a naturally occurring compound called spermidine may help improve vaccine responses in some older adults by reducing signs of immune system ageing.

Foods rich in spermadine include lentils, chickpeas, cheese and broccoli © Shutterstock

As we age, the immune system gradually declines and becomes less effective at responding to infections and vaccines. This process, known as immunosenescence, contributes to the increased risk of age-related health issues in older people and can weaken the response to vaccinations.

During the COVID-19 pandemic, over 92% of COVID-related deaths occurred in people over 60. In addition, vaccination is crucial in reducing severe illness and death, but older adults often produced lower levels of protective antibodies and T-cell responses following vaccination, for example against influenza, limiting vaccine effectiveness compared with younger populations.

Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, led by Professor Katja Simon and Associate Professor Ghada Alsaleh, set out to explore whether immune function, and therefore vaccine response, in older adults could be improved with daily spermidine supplements.

Spermidine is a naturally occurring molecule made by our cells, but it is also found in foods such as wheat germ, mushrooms and some cheeses, and previous studies have suggested it can support cellular maintenance processes that decline with age.

Read the full story on the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences website.

 

 

 

Similar stories

Arthritis origins may begin before birth, study finds

Researchers at the Kennedy Institute have discovered that some joints may be more susceptible to inflammatory arthritis before birth, offering new insight into why rheumatoid arthritis attacks particular joints while sparing others.

Oxford researchers awarded ARIA funding to develop transformative anti-viral therapies

Three innovative research projects aimed at transforming how we protect against respiratory viruses, led by teams at the University of Oxford, have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).

Researchers uncover hidden mechanism behind a major cancer therapy target

Kennedy researchers have revealed how one of the immune system's most important regulatory pathways operates at the earliest moments of T cell activation, providing new insights that could help improve cancer immunotherapy.

Major MRC funding for Irina Udalova to unravel neutrophil behaviour across immune pathologies

Prof Irina Udalova has received a programme grant of £2.7M from the Medical Research Council (MRC) to investigate how neutrophils – a type of white blood cell that forms the body’s first line of defence – adapt their behaviour to tissue requirements and contribute to immune diseases, leading to the development of a new class of neutrophil-targeted therapeutics.

Researchers find clue to how Sjögren’s disease persists

A new study has found that a protein TRIM21 linked to Sjögren’s disease may be fuelling the condition in an unexpected way. Researchers at the Kennedy Institute of Rheumatology have discovered that during a specific type of cell death, TRIM21 is released and combines with antibodies to overstimulate the immune system, potentially maintaining the symptoms of Sjögren’s disease.

New study reveals how blood cell production responds to parasite infection

Research led by the Nerlov Group in the MRC Molecular Haematology Unit provides the first detailed explanation of how parasite-fighting immune cells are selectively increased following infection.

Similar stories

Arthritis origins may begin before birth, study finds

Researchers at the Kennedy Institute have discovered that some joints may be more susceptible to inflammatory arthritis before birth, offering new insight into why rheumatoid arthritis attacks particular joints while sparing others.

Oxford researchers awarded ARIA funding to develop transformative anti-viral therapies

Three innovative research projects aimed at transforming how we protect against respiratory viruses, led by teams at the University of Oxford, have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).

Researchers uncover hidden mechanism behind a major cancer therapy target

Kennedy researchers have revealed how one of the immune system's most important regulatory pathways operates at the earliest moments of T cell activation, providing new insights that could help improve cancer immunotherapy.

Major MRC funding for Irina Udalova to unravel neutrophil behaviour across immune pathologies

Prof Irina Udalova has received a programme grant of £2.7M from the Medical Research Council (MRC) to investigate how neutrophils – a type of white blood cell that forms the body’s first line of defence – adapt their behaviour to tissue requirements and contribute to immune diseases, leading to the development of a new class of neutrophil-targeted therapeutics.

Researchers find clue to how Sjögren’s disease persists

A new study has found that a protein TRIM21 linked to Sjögren’s disease may be fuelling the condition in an unexpected way. Researchers at the Kennedy Institute of Rheumatology have discovered that during a specific type of cell death, TRIM21 is released and combines with antibodies to overstimulate the immune system, potentially maintaining the symptoms of Sjögren’s disease.

New study reveals how blood cell production responds to parasite infection

Research led by the Nerlov Group in the MRC Molecular Haematology Unit provides the first detailed explanation of how parasite-fighting immune cells are selectively increased following infection.